BIVI · BioVie Inc. Class A Common Stock
View on chartInsiders & Stakes
| PEIZER TERREN S Director | ▲ Buy | Grant | 23,166,210 Shares held | 8/15/2022 | View profile |
| James Paul Lang Director | ▲ Buy | Grant | 68,622 Shares held | 11/23/2022 | View profile |
| Adams Jonathan M EVP Liver Cirrhosis Programs | ▼ Sell | Gift | 48,630 Shares held | 2/2/2022 | View profile |
| MARKHAM PENELOPE EVP Liver Cirrhosis R&D | ▼ Sell | Tax Withholding | 47,841 Shares held | 2/16/2023 | View profile |
| Steve Gorlin Director | ▼ Sell | Open Market | 46,358 Shares held | 12/1/2023 | View profile |
| Robert J. Hariri Director | ▲ Buy | Grant | 42,254 Shares held | 11/9/2023 | View profile |
| Richard J. Berman Director | ▲ Buy | Grant | 40,643 Shares held | 11/20/2024 | View profile |
| Ahlem Clarence N. EVP Neuroscience Product Dev. | ▼ Sell | Tax Withholding | 37,148 Shares held | 2/16/2023 | View profile |
| READING CHRISTOPHER EVP Neuroscience R&D | ▼ Sell | Tax Withholding | 37,148 Shares held | 2/16/2023 | View profile |
| Sigmund Rogich Director | ▲ Buy | Grant | 36,926 Shares held | 11/20/2024 | View profile |
| Cuong Do V President & CEO | ▲ Buy | Open Market | 16,117 Shares held | 8/27/2026 | View profile |
| Joseph M. Palumbo Chief Medical Officer | ▲ Buy | Open Market | 6,036 Shares held | 8/28/2026 | View profile |
| Joanne Wendy Kim Chief Financial Officer | ▲ Buy | Open Market | 3,441 Shares held | 8/28/2026 | View profile |
| Chappell Amy Suzon Director | ▲ Buy | Open Market | 727 Shares held | 8/28/2026 | View profile |
Transaction History
| Joseph M. Palumbo | ▲ Buy | Open Market | 4,843 | $10K | 8/28/2026 |
| Chappell Amy Suzon | ▲ Buy | Open Market | 727 | $2K | 8/28/2026 |
| Joanne Wendy Kim | ▲ Buy | Open Market | 2,500 | $5K | 8/28/2026 |
| Cuong Do V | ▲ Buy | Open Market | 15,210 | $32K | 8/27/2026 |
| Cuong Do V | ▲ Buy | Open Market | 5,000 | — | 8/7/2025 |
| Sigmund Rogich | ▲ Buy | Grant | 32,700 | $0 | 11/20/2024 |
| Richard J. Berman | ▲ Buy | Grant | 34,200 | $0 | 11/20/2024 |
| Joseph M. Palumbo | ▲ Buy | Grant | 116,000 | $0 | 6/24/2024 |
| Joseph M. Palumbo | ▼ Sell | Tax Withholding | 29,000 | $14K | 6/24/2024 |
| Joanne Wendy Kim | ▲ Buy | Grant | 73,000 | $0 | 6/24/2024 |
| Joanne Wendy Kim | ▼ Sell | Tax Withholding | 18,250 | $9K | 6/24/2024 |
| Cuong Do V | ▲ Buy | Grant | 168,000 | $0 | 6/24/2024 |
| Cuong Do V | ▼ Sell | Tax Withholding | 42,000 | $20K | 6/24/2024 |
| Cuong Do V | ▲ Buy | Open Market | 10,000 | — | 3/4/2024 |
| Joseph M. Palumbo | ▼ Sell | Tax Withholding | 2,476 | $3K | 2/15/2024 |
| Joanne Wendy Kim | ▼ Sell | Tax Withholding | 2,476 | $3K | 2/15/2024 |
| Cuong Do V | ▼ Sell | Tax Withholding | 4,953 | $6K | 2/15/2024 |
| Joanne Wendy Kim | ▲ Buy | Grant | 5,000 | $0 | 12/11/2023 |
| Steve Gorlin | ▼ Sell | Open Market | 75,680 | $128K | 12/1/2023 |
| Cuong Do V | ▲ Buy | Open Market | 10,000 | $18K | 11/30/2023 |
| Steve Gorlin | ▲ Buy | Grant | 46,358 | $0 | 11/9/2023 |
| Sigmund Rogich | ▲ Buy | Grant | 42,254 | $0 | 11/9/2023 |
| Robert J. Hariri | ▲ Buy | Grant | 42,254 | $0 | 11/9/2023 |
| Richard J. Berman | ▲ Buy | Grant | 51,830 | $0 | 11/9/2023 |
| Steve Gorlin | ▼ Sell | Open Market | 8,560 | $26K | 9/5/2023 |
| Richard J. Berman | ▼ Sell | Open Market | 10,805 | $38K | 8/22/2023 |
| Cuong Do V | ▲ Buy | Grant | 149,500 | $0 | 6/29/2023 |
| Cuong Do V | ▲ Buy | Option Exercise | 41,506 | — | 6/21/2023 |
| Richard J. Berman | ▼ Sell | Open Market | 5,984 | $35K | 6/7/2023 |
| Richard J. Berman | ▼ Sell | Open Market | 5,000 | $33K | 5/22/2023 |
| Richard J. Berman | ▼ Sell | Open Market | 5,000 | $43K | 3/28/2023 |
| Richard J. Berman | ▼ Sell | Open Market | 2,613 | $22K | 3/28/2023 |
| Richard J. Berman | ▼ Sell | Open Market | 3,371 | $29K | 3/27/2023 |
| Joseph M. Palumbo | ▼ Sell | Tax Withholding | 2,476 | $14K | 2/16/2023 |
| Joanne Wendy Kim | ▼ Sell | Tax Withholding | 2,476 | $14K | 2/16/2023 |
| Cuong Do V | ▼ Sell | Tax Withholding | 4,953 | $27K | 2/16/2023 |
| Joseph M. Palumbo | ▼ Sell | Tax Withholding | 2,476 | $15K | 2/16/2023 |
| Cuong Do V | ▼ Sell | Tax Withholding | 4,953 | $30K | 2/16/2023 |
| Joanne Wendy Kim | ▼ Sell | Tax Withholding | 2,476 | $15K | 2/16/2023 |
| Ahlem Clarence N. | ▼ Sell | Tax Withholding | 2,476 | $15K | 2/16/2023 |
| READING CHRISTOPHER | ▼ Sell | Tax Withholding | 2,476 | $15K | 2/16/2023 |
| MARKHAM PENELOPE | ▼ Sell | Tax Withholding | 2,476 | $15K | 2/16/2023 |
| Steve Gorlin | ▲ Buy | Grant | 34,240 | $0 | 11/23/2022 |
| James Paul Lang | ▲ Buy | Grant | 43,578 | $0 | 11/23/2022 |
| READING CHRISTOPHER | ▲ Buy | Grant | 39,624 | $0 | 11/23/2022 |
| Robert J. Hariri | ▲ Buy | Grant | 34,240 | $0 | 11/23/2022 |
| Joseph M. Palumbo | ▲ Buy | Grant | 39,624 | $0 | 11/23/2022 |
| Ahlem Clarence N. | ▲ Buy | Grant | 39,624 | $0 | 11/23/2022 |
| Richard J. Berman | ▲ Buy | Grant | 43,578 | $0 | 11/23/2022 |
| Joanne Wendy Kim | ▲ Buy | Grant | 39,624 | $0 | 11/23/2022 |
| Cuong Do V | ▲ Buy | Grant | 79,248 | $0 | 11/23/2022 |
| MARKHAM PENELOPE | ▲ Buy | Grant | 39,624 | $0 | 11/23/2022 |
| PEIZER TERREN S | ▲ Buy | Grant | 3,636,364 | $6.0M | 8/15/2022 |
| Adams Jonathan M | ▼ Sell | Gift | 1,000 | $0 | 2/2/2022 |
| Cuong Do V | ▲ Buy | Grant | 21,710 | $0 | 12/31/2021 |
| Joanne Wendy Kim | ▲ Buy | Open Market | 2,000 | $11K | 12/7/2021 |
| Adams Jonathan M | ▼ Sell | Gift | 10,000 | $0 | 6/16/2021 |
| PEIZER TERREN S | ▲ Buy | Grant | 8,361,308 | — | 6/10/2021 |
| PEIZER TERREN S | ▲ Buy | Grant | 5,359,832 | — | 9/22/2020 |
| PEIZER TERREN S | ▲ Buy | Option Exercise | 1,549,750 | $155 | 9/22/2020 |
| PEIZER TERREN S | ▲ Buy | Grant | 1,600 | $0 | 1/2/2020 |
| Richard J. Berman | ▲ Buy | Grant | 1,600 | $0 | 1/2/2020 |
| PEIZER TERREN S | ▲ Buy | Grant | 4,422 | — | 1/2/2020 |
| PEIZER TERREN S | ▲ Buy | Grant | 1,125,000 | — | 9/24/2019 |
| PEIZER TERREN S | ▲ Buy | Grant | 1,526,334 | $68.7M | 6/24/2019 |
| PEIZER TERREN S | ▲ Buy | Grant | 1,600 | $0 | 1/2/2019 |
| PEIZER TERREN S | ▼ Sell | Other | 1,600,000 | — | 8/13/2018 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
BioVie Featured on Bloomberg Television Segment
BioVie was included in a new episode of The Street Show airing on Bloomberg Television. The segment also featured Glint, Sagtec Global, and SafeSpace Global. This media appearance provides additional visibility for the company to a financial audience.
BioVie Featured on Bloomberg Television Segment. BioVie was included in a new episode of The Street Show airing on Bloomberg Television. The segment also featured Glint, Sagtec Global, and SafeSpace Global. This media appearance provides additional visibility for the company to a financial audience.